206 related articles for article (PubMed ID: 21395066)
1. [Formation and participation of nano-amyloids in pathogenesis of Alzheimer's disease and other amyloidogenic diseases].
Mal'tsev AV; Galzitskaia OV
Biomed Khim; 2010; 56(6):624-38. PubMed ID: 21395066
[TBL] [Abstract][Full Text] [Related]
2. The role of β-amyloid peptide in neurodegenerative diseases.
Maltsev AV; Bystryak S; Galzitskaya OV
Ageing Res Rev; 2011 Sep; 10(4):440-52. PubMed ID: 21406255
[TBL] [Abstract][Full Text] [Related]
3. Not Oligomers but Amyloids are Cytotoxic in the Membrane-Mediated Amyloidogenesis of Amyloid-β Peptides.
Itoh N; Takada E; Okubo K; Yano Y; Hoshino M; Sasaki A; Kinjo M; Matsuzaki K
Chembiochem; 2018 Mar; 19(5):430-433. PubMed ID: 29235220
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
5. [Intensive protein synthesis in neurons and phosphorylation of beta-amyloid precursor protein and tau-protein are triggering factors of neuronal amyloidosis and Alzheimer's disease].
Mal'tsev AV; Davidchenko NV; Uteshev VK; Sokolik VV; Shtang OM; Iakushun MA; Sokolova NM; Suprin AK; Galzitskaia OV
Biomed Khim; 2013; 59(2):144-70. PubMed ID: 23789343
[TBL] [Abstract][Full Text] [Related]
6. Synaptotoxic amyloid-β oligomers: a molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease?
Klein WL
J Alzheimers Dis; 2013; 33 Suppl 1():S49-65. PubMed ID: 22785404
[TBL] [Abstract][Full Text] [Related]
7. Astrocytes contain amyloid-β annular protofibrils in Alzheimer's disease brains.
Lasagna-Reeves CA; Kayed R
FEBS Lett; 2011 Oct; 585(19):3052-7. PubMed ID: 21872592
[TBL] [Abstract][Full Text] [Related]
8. The progression towards Alzheimer's disease described as a bistable switch arising from the positive loop between amyloids and Ca(2+).
De Caluwé J; Dupont G
J Theor Biol; 2013 Aug; 331():12-8. PubMed ID: 23614875
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease: β-amyloid plaque formation in human brain.
Seeman P; Seeman N
Synapse; 2011 Dec; 65(12):1289-97. PubMed ID: 21633975
[TBL] [Abstract][Full Text] [Related]
10. Intraneuronal β-amyloid and its interactions with proteins and subcellular organelles.
Penke B; Tóth AM; Földi I; Szűcs M; Janáky T
Electrophoresis; 2012 Dec; 33(24):3608-16. PubMed ID: 23161402
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
12. Does the electrical activity of neurons contribute to the pathogenesis of Alzheimer's Disease?
Concepcion GP; Padlan EA
Med Hypotheses; 2010 Jan; 74(1):27-8. PubMed ID: 19733011
[TBL] [Abstract][Full Text] [Related]
13. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.
Phiel CJ; Wilson CA; Lee VM; Klein PS
Nature; 2003 May; 423(6938):435-9. PubMed ID: 12761548
[TBL] [Abstract][Full Text] [Related]
14. Biology of amyloid: structure, function, and regulation.
Greenwald J; Riek R
Structure; 2010 Oct; 18(10):1244-60. PubMed ID: 20947013
[TBL] [Abstract][Full Text] [Related]
15. Negatively charged gold nanoparticles inhibit Alzheimer's amyloid-β fibrillization, induce fibril dissociation, and mitigate neurotoxicity.
Liao YH; Chang YJ; Yoshiike Y; Chang YC; Chen YR
Small; 2012 Dec; 8(23):3631-9. PubMed ID: 22915547
[TBL] [Abstract][Full Text] [Related]
16. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
[TBL] [Abstract][Full Text] [Related]
17. A cell biological perspective on Alzheimer's disease.
Annaert W; De Strooper B
Annu Rev Cell Dev Biol; 2002; 18():25-51. PubMed ID: 12142279
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease.
Cumming RC; Schubert D
FASEB J; 2005 Dec; 19(14):2060-2. PubMed ID: 16186172
[TBL] [Abstract][Full Text] [Related]
19. β-adrenergic receptor, amyloid β-peptide, and Alzheimer's disease.
Wang D; Xiang YK
Curr Top Membr; 2011; 67():205-28. PubMed ID: 21771492
[No Abstract] [Full Text] [Related]
20. [The influence of beta-amyloid peptide on the functions of excitable tissues: physiological and pathological aspects].
Mukhamedyarov MA; Zefirov AL
Usp Fiziol Nauk; 2013; 44(1):55-71. PubMed ID: 23662474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
